1. Home
  2. BNGO vs UBX Comparison

BNGO vs UBX Comparison

Compare BNGO & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNGO
  • UBX
  • Stock Information
  • Founded
  • BNGO 2003
  • UBX 2009
  • Country
  • BNGO United States
  • UBX United States
  • Employees
  • BNGO N/A
  • UBX N/A
  • Industry
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNGO Industrials
  • UBX Health Care
  • Exchange
  • BNGO Nasdaq
  • UBX Nasdaq
  • Market Cap
  • BNGO 24.3M
  • UBX 24.6M
  • IPO Year
  • BNGO 2018
  • UBX 2018
  • Fundamental
  • Price
  • BNGO $0.20
  • UBX $0.96
  • Analyst Decision
  • BNGO Hold
  • UBX Strong Buy
  • Analyst Count
  • BNGO 3
  • UBX 1
  • Target Price
  • BNGO $1.00
  • UBX $8.00
  • AVG Volume (30 Days)
  • BNGO 3.0M
  • UBX 93.3K
  • Earning Date
  • BNGO 11-13-2024
  • UBX 11-04-2024
  • Dividend Yield
  • BNGO N/A
  • UBX N/A
  • EPS Growth
  • BNGO N/A
  • UBX N/A
  • EPS
  • BNGO N/A
  • UBX N/A
  • Revenue
  • BNGO $33,334,000.00
  • UBX N/A
  • Revenue This Year
  • BNGO N/A
  • UBX N/A
  • Revenue Next Year
  • BNGO $6.18
  • UBX $33.62
  • P/E Ratio
  • BNGO N/A
  • UBX N/A
  • Revenue Growth
  • BNGO N/A
  • UBX N/A
  • 52 Week Low
  • BNGO $0.20
  • UBX $0.95
  • 52 Week High
  • BNGO $2.27
  • UBX $2.02
  • Technical
  • Relative Strength Index (RSI)
  • BNGO 31.53
  • UBX 26.17
  • Support Level
  • BNGO $0.20
  • UBX $1.10
  • Resistance Level
  • BNGO $0.28
  • UBX $1.23
  • Average True Range (ATR)
  • BNGO 0.02
  • UBX 0.07
  • MACD
  • BNGO -0.00
  • UBX -0.02
  • Stochastic Oscillator
  • BNGO 0.00
  • UBX 4.46

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: